ATE443520T1 - Zusammensetzungen, hepoxilinanaloga enthaltend, und deren verwendung in der krebsbehandlung - Google Patents

Zusammensetzungen, hepoxilinanaloga enthaltend, und deren verwendung in der krebsbehandlung

Info

Publication number
ATE443520T1
ATE443520T1 AT03724735T AT03724735T ATE443520T1 AT E443520 T1 ATE443520 T1 AT E443520T1 AT 03724735 T AT03724735 T AT 03724735T AT 03724735 T AT03724735 T AT 03724735T AT E443520 T1 ATE443520 T1 AT E443520T1
Authority
AT
Austria
Prior art keywords
compositions containing
cancer treatment
hepoxilin analogs
hepoxilin
analogs
Prior art date
Application number
AT03724735T
Other languages
English (en)
Inventor
Cecil Pace-Asciak
Original Assignee
Pace Asciak Cecil R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pace Asciak Cecil R filed Critical Pace Asciak Cecil R
Application granted granted Critical
Publication of ATE443520T1 publication Critical patent/ATE443520T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03724735T 2002-05-28 2003-05-28 Zusammensetzungen, hepoxilinanaloga enthaltend, und deren verwendung in der krebsbehandlung ATE443520T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38313402P 2002-05-28 2002-05-28
PCT/CA2003/000780 WO2003099285A1 (en) 2002-05-28 2003-05-28 Compositions comprising hepoxilin analogs and their use in the treatment of cancer

Publications (1)

Publication Number Publication Date
ATE443520T1 true ATE443520T1 (de) 2009-10-15

Family

ID=29584512

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724735T ATE443520T1 (de) 2002-05-28 2003-05-28 Zusammensetzungen, hepoxilinanaloga enthaltend, und deren verwendung in der krebsbehandlung

Country Status (7)

Country Link
US (1) US7666905B2 (de)
EP (1) EP1509229B1 (de)
AT (1) ATE443520T1 (de)
AU (1) AU2003229202A1 (de)
CA (1) CA2526943C (de)
DE (1) DE60329386D1 (de)
WO (1) WO2003099285A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038157A2 (en) 2000-11-09 2002-05-16 The Hospital For Sick Children Inhibitors of thromboxane formation and action
US7943586B2 (en) 2003-06-09 2011-05-17 The Trustees Of The University Of Pennsylvania Antineoplastic agents targeted via glut transporters
WO2006106438A2 (en) * 2005-01-11 2006-10-12 Evolva Sa Modulators of ppar activity
US8710252B2 (en) 2006-04-19 2014-04-29 Cecil Pace-Asciak Hepodxilin analog enantiomers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6511794A (en) 1993-03-29 1994-10-24 Cecil R. Pace-Asciak Hepoxilin analogs useful as anti-inflammatory agents
US5789441A (en) * 1996-02-15 1998-08-04 Virocell Inc. Leukotriene B4 as an antiviral and anti-neoplastic agent
US6391305B1 (en) * 1997-09-10 2002-05-21 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
CA2330916C (en) * 1998-05-19 2011-04-05 Research Development Foundation Triterpene compositions and methods for use thereof
CA2393904C (en) 1999-08-04 2012-10-16 Hsc Research And Development Limited Partnership Hepoxilin analogs
WO2002038157A2 (en) * 2000-11-09 2002-05-16 The Hospital For Sick Children Inhibitors of thromboxane formation and action

Also Published As

Publication number Publication date
CA2526943A1 (en) 2003-12-04
EP1509229B1 (de) 2009-09-23
US20050272671A1 (en) 2005-12-08
DE60329386D1 (de) 2009-11-05
CA2526943C (en) 2011-08-09
WO2003099285A1 (en) 2003-12-04
AU2003229202A1 (en) 2003-12-12
US7666905B2 (en) 2010-02-23
EP1509229A1 (de) 2005-03-02

Similar Documents

Publication Publication Date Title
ATE435199T1 (de) Diarylharnstoffderivate und deren verwendung als chloridkanalblocker
GEP20104994B (en) Tetrahydroindolone and tetrahydroindazolone derivatives
DE60118003D1 (de) Harnstoffderivate und ihre verwendung
MX2007003546A (es) Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa.
BRPI0418251C1 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
ATE327977T1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
ES2193949T3 (es) Nuevos derivados del acido lipoico, su preparacion y composiciones farmaceuticas que los contienen.
BRPI0416692A (pt) inibidores heterocìclicos de mek e métodos de emprego destes
UY29246A1 (es) Nuevos compuestos
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
DE602004024213D1 (en) Aminopropanolderivate
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
ATE499098T1 (de) Verwendung von parp-1-hemmern
EA200401319A1 (ru) Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине
DE60311887D1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung
TW200626527A (en) Novel hexafluoroisopropanol derivatives
ATE443520T1 (de) Zusammensetzungen, hepoxilinanaloga enthaltend, und deren verwendung in der krebsbehandlung
DE602007010430D1 (de) Camptothecinderivate und ihre verwendung
SE0300457D0 (sv) Novel compounds
EA200702672A1 (ru) Производные индола, обладающие противоопухолевой активностью
ATE393624T1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
ATE411301T1 (de) Diphenylurea-derivative und ihre verwendung als chloridkanalblocker
UY26179A1 (es) Amidas sustituidas del ácido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporación de adenosina.
IL174365A (en) Bravatoxin Polyether Compounds, Pharmaceutical Formulations and the Use of Drug Preparation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties